Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Diamond Biofund Inc. is a biotechnology investment firm based in Taiwan, founded in 2013. It holds the distinction of being the first publicly listed sustainable biotech venture capital firm in Taiwan. The firm is dedicated to supporting innovative biotechnology companies by providing not only capital but also essential resources aimed at enhancing governance, technology development, clinical execution, and overall business growth.
As of now, Diamond Biofund manages a diverse portfolio of over 20 biotechnology startups, showcasing its commitment to fostering innovation in the biotech sector. The firm operates with a global perspective, particularly focusing on opportunities in Asia. Its notable milestones include establishing a strong presence in the biotech investment landscape and actively participating in corporate governance and financial reporting.
Diamond Biofund specializes in investments within the biotechnology and medical sectors, targeting global opportunities across various domains. These include new drug development, advanced medical devices, innovative medical services, and agricultural biotechnology. The firm is particularly interested in early-stage companies that demonstrate potential for significant impact in their respective fields.
Investment stages range from pre-seed to Series A, allowing Diamond Biofund to engage with startups at different points in their development. The firm emphasizes providing strategic support alongside capital, focusing on operational aspects such as research and development, finance, and corporate governance. This approach aims to identify and nurture companies that possess international competitiveness and address unmet medical needs.
Diamond Biofund has invested in over 20 biotechnology startups, showcasing a diverse range of innovative companies. Notable portfolio companies include:
This portfolio reflects Diamond Biofund's commitment to advancing biotechnology and healthcare solutions, with a focus on companies that are positioned to make a meaningful impact in their industries.
Yang Pan-Chih - Chairman. Yang has extensive experience in the biotech sector and has played a pivotal role in establishing Diamond Biofund as a leader in sustainable biotech investments.
Lee Tsu-Te - Vice Chairman. Lee brings a wealth of knowledge in venture capital and has been instrumental in guiding the firm's investment strategy.
Wu You-Mei - General Manager. Wu oversees the day-to-day operations of Diamond Biofund and is responsible for managing the firm's portfolio and investment activities.
Huang Yan-Zhen - Chief Financial Officer. Huang manages the financial operations of the firm, ensuring sound financial practices and reporting.
To pitch Diamond Biofund, founders should visit their website at diamondbiofund.com. It is advisable to include a comprehensive deck that outlines the business model, market opportunity, and competitive landscape. Specific details regarding response times or preferred channels for communication were not provided.
Warm introductions may enhance the chances of securing a meeting, but the firm does not specify a strict requirement for this. Founders should ensure their pitch clearly communicates the innovative aspects of their technology and the potential impact on the healthcare sector.
In early March 2026, Diamond Biofund has been active in corporate governance and financial reporting, with multiple announcements regarding board resolutions and financial reports. The firm has also published updates on its blog, detailing recent investment activities and governance decisions.
These updates reflect Diamond Biofund's ongoing commitment to transparency and engagement with its stakeholders, reinforcing its position as a leader in the biotech investment space.
What are Diamond Biofund's investment criteria?
Diamond Biofund focuses on early-stage biotechnology and medical companies, particularly those involved in new drug development, advanced medical devices, and innovative medical services. The firm seeks startups that demonstrate potential for significant growth and address unmet medical needs.
How can I pitch to Diamond Biofund?
Founders interested in pitching to Diamond Biofund should visit their website at diamondbiofund.com for more information on the application process. Specific email addresses for pitches were not provided.
What makes Diamond Biofund different from other VCs?
Diamond Biofund is distinguished by its status as the first publicly listed sustainable biotech venture capital firm in Taiwan. The firm not only provides capital but also offers strategic support in governance, technology development, and clinical execution.
What is the geographic scope of Diamond Biofund's investments?
Diamond Biofund targets global investment opportunities, with a particular focus on the Asian market. This allows them to engage with a diverse range of biotechnology startups.
What is the typical check size for investments?
While specific check sizes are not disclosed, Diamond Biofund invests across various stages, including pre-seed, seed, seed-plus, and Series A, indicating a flexible approach to funding.
What kind of post-investment support does Diamond Biofund provide?
Diamond Biofund offers strategic operational assistance, including support in research and development, finance, and corporate governance, to help portfolio companies grow and succeed.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.